Press release Date: 10 Dec 2003
Subject: Safety review of antidepressants used by children completed (reference 2003/0505)
Contact: Press Office 020 3080 7651
or press.office@mhra.gsi.gov.uk
Out-of-hours 07770 446 189
Professor Gordon Duff, Chairman of the Committee on Safety of Medicines, said:
"The CSM Expert Group has delivered comprehensive advice on the use of these drugs in children and young people following a thorough review of all the evidence available. This gives parents, young people and those who treat these devastating illnesses the information they need to make informed decisions about treatment."
"Like Seroxat and Efexor, none of these drugs has ever been licensed for use in those under 18."
"We know, however, they are used in this age group outside of their licensed indications where prescribers make a judgement on their own responsibility that it is the correct treatment for a particular patient.
"It is therefore important that patients, parents and doctors are aware of the new advice. Young people with depressive illness currently taking any SSRI other than fluoxetine should not stop taking their medicine but should consult their doctor for advice on treatment".
http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON002045
Subject: Safety review of antidepressants used by children completed (reference 2003/0505)
Contact: Press Office 020 3080 7651
Out-of-hours 07770 446 189
Professor Gordon Duff, Chairman of the Committee on Safety of Medicines, said:
"The CSM Expert Group has delivered comprehensive advice on the use of these drugs in children and young people following a thorough review of all the evidence available. This gives parents, young people and those who treat these devastating illnesses the information they need to make informed decisions about treatment."
"Like Seroxat and Efexor, none of these drugs has ever been licensed for use in those under 18."
"We know, however, they are used in this age group outside of their licensed indications where prescribers make a judgement on their own responsibility that it is the correct treatment for a particular patient.
"It is therefore important that patients, parents and doctors are aware of the new advice. Young people with depressive illness currently taking any SSRI other than fluoxetine should not stop taking their medicine but should consult their doctor for advice on treatment".
http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON002045
No comments:
Post a Comment
Note: only a member of this blog may post a comment.